Keiferx
KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Keiferx
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- WH
William Hoyt
Project Manager · Science
EmailPhone - CH
Chris Hoyt
Chief Executive Officer · Other
EmailPhone - FP
Fernando Pagan
Co-founder and Board Member · General Business & Management
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Keiferx
3 distinct titles indexed · top 3 shown.
- 1chief executive officer
- 1co-founder and board member
- 1project manager
Sign up to unlock all 4 contacts at Keiferx
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Keiferx
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.